PURCHASE OF TACROLIMUS XL 3 MG

Auto-translated from Spanish

Original title: ADQUISICION TACROLIMUS XL 3 MG

Published: Aug 31, 2026

Updated: Aug 31, 2026

Source: chile_mercadopublico

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Chile, Latin America, this opportunity is open to firms and consortiums. Proposals must be submitted before September 10, 2026.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Spanish

This tender, originating from Chile and sourced via chile_mercadopublico, seeks the procurement of Tacrolimus XL 3 mg. This is a pharmaceutical acquisition, focusing on a specific medication with extended-release properties. The contracting authority is looking to secure a supply of this drug, which is commonly used in organ transplantation to prevent rejection and in the treatment of certain autoimmune diseases. Typical requirements for such a tender would include stringent quality control measures, adherence to pharmaceutical manufacturing standards (e.g., Good Manufacturing Practices - GMP), and a reliable supply chain. Bidders are expected to demonstrate their capacity to provide the specified dosage and formulation, along with necessary certifications and product documentation. The tender likely requires the submission of detailed product specifications, evidence of regulatory approval in Chile, and proposals for delivery timelines and quantities. Ensuring the integrity and efficacy of the pharmaceutical product throughout its lifecycle, from manufacturing to delivery, will be a critical evaluation criterion. This procurement aims to ensure the availability of essential medication for patients within the Chilean healthcare system.

Data provenance

This notice is sourced from Chile Mercado Publico and was originally published on August 31, 2026. Last refreshed today. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

Frequently asked questions about this tender

How can I submit a bid?

Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 10, 2026. You have 10 days left to prepare and submit your proposal to the contracting authority.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.